Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain.
Fukuoka M, Takahashi M, Fujita H, Chiyo T, Popiel HA, Watanabe S, Furuya H, Murata M, Wada K, Okada T, Nagai Y, Hohjoh H.
Fukuoka M, et al. Among authors: wada k.
Mol Ther Nucleic Acids. 2018 Jun 1;11:79-90. doi: 10.1016/j.omtn.2018.01.007. Epub 2018 Feb 2.
Mol Ther Nucleic Acids. 2018.
PMID: 29858092
Free PMC article.